Dopamine beta-hydroxylase gene excluded in four subtypes of hereditary dystonia.
The hereditary dystonias include a clinically heterogeneous group of movement disorders varying in symptoms, age of onset, and drug responsiveness. Dopamine beta-hydroxylase (DBH), the enzyme that converts dopamine to norepinephrine, has been implicated in dystonia because of increased serum levels of DBH in some patients, the influence of catecholaminergic drugs on the human phenotypes, and altered norepinephrine levels in several brain regions in dystonia patients and in genetically dystonic rodents. In addition, markers linked to the dystonia gene in two ethnic groups map close to the DBH locus on human chromosome 9q34. Here we evaluate the inheritance of restriction fragment length polymorphisms near the DBH gene in families with four subtypes of hereditary dystonia: Jewish and non-Jewish, early onset, generalized idiopathic torsion dystonia (ITD); dopa-responsive dystonia; and myoclonic dystonia. In all families, obligate recombination events were observed between the DBH and dystonia genes, thus excluding the DBH gene as the primary defect.
Molecular Neurogenetics Unit, Massachusetts General Hospital, Boston 02114.
D
D
Schuback
P
P
Kramer
L
L
Ozelius
G
G
Holmgren
L
L
Forsgren
M
M
Kyllerman
J
J
Wahlström
C M
CM
Craft
T
T
Nygaard
M
M
Brin
D000293:Adolescent; D000328:Adult; D000483:Alleles; D002170:Canada; D002460:Cell Line; D002648:Child; D002675:Child, Preschool; D004299:Dopamine beta-Hydroxylase / Q000235:genetics*; D004421:Dystonia / Q000201:enzymology / Q000208:ethnology / Q000235:genetics*; D005260:Female; D005602:France; D008040:Genetic Linkage; D006801:Humans; D007585:Jews / Q000235:genetics; D008297:Male; D010375:Pedigree; D012150:Polymorphism, Restriction Fragment Length; D013548:Sweden
D004299:Dopamine beta-Hydroxylase